Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alirocumab
alnylam pharmaceuticals
amgen
analytics
bank
biotech
boston blog main
boston top stories
clinical trials
deals
evolocumab
fda
financial services
inclisiran
insurance
life sciences
national blog main
national top stories
new york
new york blog main
new york top stories
novartis
oscar
pcsk9
pcsk9 inhibitors
peer-to-peer lending
regeneron pharmaceuticals
rna interference
sanofi
tc
the medicines company
united states
What
cash
2
×
ready
2
×
abound
acquire
agreed
ahead
automotive
billion
brings
business
cable
chart
cholesterol
commercial
companies
company
compound
consistently
cool
customer
deal
disruption
drug
estate
fda
flow
highlighting
industries
insurance
life
makes
medco
medical
medicines
new
novartis
opportunities
outlays
poised
potential
Language
unset
Current search:
ready
×
cash
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@techcrunch.com
8 years ago
Opportunities In The Risk Business Abound As Insurance Is Ready For Disruption
